SEPN
Septerna Inc.

577
Mkt Cap
$950.11M
Volume
116,890.00
52W High
$28.99
52W Low
$4.17
PE Ratio
-9.90
SEPN Fundamentals
Price
$21.31
Prev Close
$22.44
Open
$22.52
50D MA
$16.36
Beta
1.42
Avg. Volume
264,792.95
EPS (Annual)
-$1.62
P/B
2.52
Rev/Employee
$14,333.33
Loading...
Loading...
News
all
press releases
Strength Seen in Septerna, Inc. (SEPN): Can Its 7.0% Jump Turn into More Strength?
Septerna, Inc. (SEPN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks·12d ago
News Placeholder
More News
News Placeholder
Are Options Traders Betting on a Big Move in Septerna Stock?
Investors need to pay close attention to SEPN stock based on the movements in the options market lately.
Zacks·19d ago
News Placeholder
Does Septerna, Inc. (SEPN) Have the Potential to Rally 151.27% as Wall Street Analysts Expect?
Zacks·5mo ago
News Placeholder
ETFs to Capitalize on the Novo Nordisk-Septerna Deal
Zacks·5mo ago
News Placeholder
Septerna Stock Surges on Oral Obesity Drug Deal With Novo Nordisk
Zacks·5mo ago
News Placeholder
Novo Nordisk Inks $2.2B Deal With Septerna: Retail’s Thrilled
Septerna CEO Jeffrey Finer said that the collaboration allows the company to create multiple oral medicines and provides the operational flexibility and resources to advance its portfolio of other GPCR-targeted programmes.
Stocktwits·5mo ago
News Placeholder
Septerna Poised For Biopharma Breakthrough: Analysts Cite GPCR Innovation And 2025 Milestones
Analysts initiated coverage on Septerna, Inc. with Overweight ratings and price targets of $50 and $38. SEPN's innovative platform and potential pipeline make it a promising biopharma player. read...
Benzinga·11mo ago

Latest SEPN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.